Pathway Genomics – CancerIntercept® Monitor

CancerIntercept® Monitor is a blood-based tumor profiling test that provides a non-invasive and less expensive adjunct to traditional biopsy methods. This genomic profiling test provides valuable information that can be used to both personalize and monitor a patient’s oncology care.

We have not reviewed this DNA test yet. If you have taken this test, please scroll down and click “Add your review.” All DNA tests that have not been reviewed receive a default score of 6/10 until reader reviews change the score.

CancerIntercept® Monitor is a blood-based tumor profiling test that provides a non-invasive and less expensive adjunct to traditional biopsy methods. This genomic profiling test provides valuable information that can be used to both personalize and monitor a patient?s oncology care.

$199 - $2999

TAKE THE TEST